Cantitate/Preț
Produs

Thyroid Cancer


en Limba Engleză Paperback – 23 aug 2016
Comprised exclusively of clinical cases covering the diagnosis and treatment of thyroid cancer and related clinical issues, this concise, practical casebook will provide clinicians in endocrinology and oncology with the best real-world strategies to properly manage the various forms of thyroid cancer that they may encounter. Each chapter is a case report, written by recognized experts, that opens with a unique clinical presentation, followed by a description of the diagnosis, assessment and therapy, as well as the case outcome, literature review,  clinical pearls and pitfalls, and bibliography.  All recommendations are based on evidence-based clinical practice guidelines and recent literature. Cases included illustrate treatment for both low and high risk differentiated thyroid cancer, including surgical approaches, radioiodine therapy, and novel chemotherapies and targeted therapies, as well as postoperative follow-up and special issues. Additional cases demonstrate the management of medullary thyroid cancer, thyroid lymphoma and anaplastic thyroid cancer. Pragmatic and reader-friendly, Thyroid Cancer: A Case-Based Approach will be an excellent resource for clinical endocrinologists and oncologists, endocrine fellows, residents and students alike.
 
Citește tot Restrânge

Preț: 85487 lei

Preț vechi: 89985 lei
-5%

Puncte Express: 1282

Carte tipărită la comandă

Livrare economică 31 august-14 septembrie

Livrare prin curier în România Termenul estimat este afișat lângă disponibilitate.
Transport gratuit pentru acest produs Plată online sau ramburs, în funcție de opțiunile comenzii.
Retur gratuit în 14 zile Comandă securizată și suport în română.

Specificații

ISBN-13: 9783319358352
ISBN-10: 3319358359
Pagini: 448
Ilustrații: XVII, 430 p. 46 illus., 27 illus. in color.
Dimensiuni: 155 x 235 x 25 mm
Greutate: 0.67 kg
Ediția:Softcover reprint of the original 1st ed. 2016
Editura: Springer
Locul publicării:Cham, Switzerland

Cuprins

Part 1 Low Risk Differentiated Thyroid Cancer: Preoperative diagnosis.- Chapter 1 A patient with a single thyroid nodule suspicious for follicular neoplasm according to the Bethesda System for Reporting Thyroid Cytopathology: molecular evaluation.- Part 2 Low Risk Differentiated Thyroid Cancer: Initial management: extent of surgery and use of radioactive iodine therapy.- Chapter 2 A case of a small (1 to 2 cm) papillary thyroid cancer in a young patient:  lobectomy vs. total thyroidectomy.- Chapter 3 The decision-making process for prophylactic central neck dissection in a patient presenting with nodular thyroid disease suspicious for malignancy on cytology assessment: role of preoperative ultrasound and molecular marker testing.- Chapter 4 Incidentally discovered micropapillary thyroid cancer.- Chapter 5 Completion thyroidectomy in a patient with low risk papillary cancer.- Chapter 6 A case of multifocal micropapillary thyroid cancer.- Chapter 7 A papillary thyroid cancer with minimal extra-thyroidal extension .- Chapter 8 A case of a papillary thyroid cancer with lymph node metastases found on prophylactic central neck dissection (subclinical disease, micrometastases).- Chapter 9 Papillary thyroid cancer with central neck lymph node metastases.- Chapter 10 A patient with a large minimally invasive follicular thyroid cancer.-  Chapter 11 A young patient with intrathyroidal papillary thyroid cancer and family history of differentiated thyroid cancer.- Chapter 12 A child with papillary thyroid cancer and locally advanced disease but no distant metastasis.- Part 3 Low Risk Differentiated Thyroid Cancer: Postoperative follow-up.- Chapter 13 A patient with papillary thyroid cancer and biochemical evidence of disease at the 1-yr follow-up visit.- Chapter 14 Low but detectable suppressed thyroglobulin levels in thyroid cancer patients’ follow-up: How to interpret and manage these cases?.- Chapter 15 A young patient with papillary thyroidcancer and biochemical evidence of disease at the follow-up visits and increasing serum Tg values at the follow up assessments.- Chapter 16 A young patient with recurrent lymph node involvement:  imaging, cytology, Tg washout.- Part 4 Low Risk Differentiated Thyroid Cancer: Special issues.- Chapter 17 Papillary thyroid carcinoma diagnosed during pregnancy.- Chapter 18 Risks of Thyroid Hormone Suppression for Differentiated Thyroid Cancer in the Elderly.- Chapter 19 A patient in whom one pathologist says she has cancer and another says that the lesion is benign.- Chapter 20: A case with postsurgical hypoparathyroidism.- Chapter 21 A case with postsurgical recurrent laryngeal nerve damage and nerve monitoring.- Part 5 High Risk Differentiated Thyroid Cancer: The need for additional therapy.- Chapter 22 A case of papillary thyroid cancer without aggressive histological features with nodal metastases detected during follow-up in a younger patient.- Chapter 23 A case of papillary thyroid cancer without aggressive histological features with nodal metastases in an older patient.- Chapter 24 A patient with a large Hũrthle cell carcinoma of the thyroid and nodal metastases.- Chapter 25 A case of a large, invasive PTC with gross residual disease (pT4) after surgery.- Part 6 High Risk Differentiated Thyroid Cancer: The use of radioiodine.- Chapter 26 A patient with papillary carcinoma of the thyroid with elevated serum thyroglobulin but negative imaging studies.- Chapter 27 A young child with papillary thyroid cancer and metastatic pulmonary disease:  whole issue of radioactive iodine therapy in children.- Chapter 28 A patient with bone metastases from follicular carcinoma of the thyroid.- Chapter 29 Radioiodine Therapy in Lactating Women with High Risk Differentiated Thyroid Cancer.- Part 7 High Risk Differentiated Thyroid Cancer: The use of local treatments and novel systemic chemotherapies.- Chapter 30 A case of a patient with radioactiveiodine refractory differentiated thyroid cancer with progressive neck disease (latero-cervical lymph nodes) and stable, small lung metastases.- Chapter 31 A case of an elderly patient with advanced disease and non radioiodine avid metastases.- Chapter 32 Radioactive iodine refractory differentiated thyroid cancer with multiple organ progressive disease.- Chapter 33 Radioactive iodine refractory differentiated thyroid cancer and lung lesions causing bleeding.- Chapter 34 A patient with follicular thyroid cancer and a painful bone metastasis at risk for pathologic fracture.- Chapter 35 Differentiated thyroid cancer and brain .- Part 8 High Risk Differentiated Thyroid Cancer: Novel chemotherapy and toxicity.- Chapter 36 Radioactive iodine refractory, advanced differentiated thyroid cancer receiving tyrosine kinase inhibitor treatment: checking for drug-drug interactions.- Chapter 37 A patient with advanced differentiated radioactive iodine-refractory thyroid cancer receiving tyrosine kinase inhibitor treatment: managing hypertension, QTc prolongation, dermatologic and gastrointestinal adverse events.- Part 9 Medullary Thyroid Cancer: Postoperative management.- Chapter 38 Management of post-operative hypercalcitoninemia in medullary thyroid cancer.- Chapter 39 A patient with metastatic medullary thyroid carcinoma (MTC) and tumor-related diarrhea.- Chapter 40 Clinical management of a patient with a locally recurrent medullary thyroid cancer and asymptomatic slowly progressing distant metastases.- Chapter 41 A patient with an advanced medullary thyroid cancer and progressive, symptomatic distant metastases: when to start systemic therapy.- Chapter 42 Medical Treatment Decision-Making for Advanced, Progressive Medullary Thyroid Cancer.- Part 10 Medullary Thyroid Cancer: Special issues.- Chapter 43 Screening leading to diagnosis of C cell hyperplasia.- Chapter 44 Increased basal calcitonin in nodular goiter: Is it micromedullary thyroid cancer?.- Chapter 45 Timing and extent of surgery for a pediatric patient with hereditary MTC and positive screening for the S891A RET mutation .- Part 11 Thyroid lymphoma.- Chapter 46 Thyroid Lymphoma: Differential Diagnosis .- Part 12 Anaplastic thyroid cancer.- Chapter 47 Anaplastic Thyroid Cancer: Surgery or Not in Locally Advanced Disease.

Notă biografică

David S. Cooper, MD, Professor of Medicine, Division of Endocrinology, Diabetes, and Metabolism, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Cosimo Durante, MD, Department of Internal Medicine, University of Rome - Sapienza, Rome, Italy

Textul de pe ultima copertă

Comprised exclusively of clinical cases covering the diagnosis and treatment of thyroid cancer and related clinical issues, this concise, practical casebook will provide clinicians in endocrinology and oncology with the best real-world strategies to properly manage the various forms of thyroid cancer that they may encounter. Each chapter is a case report, written by recognized experts, that opens with a unique clinical presentation, followed by a description of the diagnosis, assessment and therapy, as well as the case outcome, literature review,  clinical pearls and pitfalls, and bibliography.  All recommendations are based on evidence-based clinical practice guidelines and recent literature. Cases included illustrate treatment for both low and high risk differentiated thyroid cancer, including surgical approaches, radioiodine therapy, and novel chemotherapies and targeted therapies, as well as postoperative follow-up and special issues. Additional cases demonstrate the management of medullary thyroid cancer, thyroid lymphoma and anaplastic thyroid cancer. Pragmatic and reader-friendly, Thyroid Cancer: A Case-Based Approach will be an excellent resource for clinical endocrinologists and oncologists, endocrine fellows, residents and students alike.
 

Caracteristici

A cased-based, practical guide to the management of various forms of thyroid cancer and associated clinical issues Discusses history, diagnosis and treatment of low and high risk differentiated thyroid cancer, medullary thyroid cancer, thyroid lymphoma and anaplastic thyroid cancer An excellent resource for practicing clinicians, residents and students alike

Recenzii

From the reviews
"...our present state of knowledge provides clinicians a wide variety of diagnostic and therapeutic modalities to effectively manage this group of cancers. I believe the knowledge contained in this text will give the practicing clinician the necessary information to provide patients the latest and best therapeutic techniques."-Foreword by Ernest L. Mazzaferri, MD

"This is an excellent comprehensive up-to-date text that is scholarly and complete, yet thoroughly readable. It provides guidance to clinicians and others interested in thyroid cancer based on a combination of a distillate of the published literature [which is fully documented] and the personal experience of the expert author of each chapter. . .the text reads quickly. . . I recommend this text to anyone interested in an up-to-date, detailed, clinical guideline to the management of patients with thyroid cancer and the clinical science behind the recommendation."-Journal of Nuclear Medicine

"This book illustrates the importance of the multidisciplinary approach available in major medical centers for the care of patients with thyroid cancer. The wide-ranging topical nature of this book will interest those working in many fields of medicine. It should be essential reading for trainees in endocrinology, pathology, imaging, nuclear medicine, surgery, and oncology, as well as for specialists in those fields."-The New England Journal of Medicine

"The book is truly unique and is a critical addition to the contemporary endocrine texts held by general physicians, surgeons, and endocrinologists alike. The book is designed to be a comprehensive guide for clinical management of thyroid cancer and in this regard, is an overwhelming success...One of the most important aspects of this text is the multidisciplinary emphasis provided to all the sub specialists who attend patients with thyroid neoplasms... The book is uniquely organized with several chapters exclusively devoted to the surgical and medical management of individual types of thyroid cancer. This organization is important, because it helps emphasize that each thyroid cancer is unique and not necessarily amenable to one standardized form of treatment...A parallel emphasis of the book is the reliance on evidence-based practice...each chapter is thoroughly referenced, making it easy for the reader to ascertain the original studies on which these conclusions and controversy are based....One of the strengths of this book is the devotion of separate chapters to the management of unique thyroid cancers and unique patients...The text is right up -to- date with regards to the molecular biology of thyroid cancers, the management of medullary thyroid carcinoma, the use of alternative imaging techniques and the use of rhTSH for scanning patients with a history of thyroid cancer...To conclude, this is a unique and important text for all practitioners caring for patients with thyroid cancer. I congratulate the Editor and Authors for their success in detailing this complex and rapidly changing field." ------Trends in Endocrinology and Metabolism

"...recommended for anyone who would like a comprehensive reference on the practical aspects of thyroid cancer management." - Head & Neck

"This comprehensive book brings an instructive review of present knowledge on the pathology, etiology, epidemiology, diagnostic methods and the methods of surgical, radioiodine and chemotherapeutic treatment of various forms of thyroid cancer. Written by outstanding experts and professionally edited by Leonard Wartofsky, it may be considered of substantial utility to all physicians dealing with thyroid diseases." - Endocrine Regulations
From the reviews of the second edition:
"An excellent, truly comprehensive book that covers the etiology, pathogenesis, and clinical management of all forms of thyroid cancer. … While the book is written clearly enough to be accessibleto physicians in training, it will probably be most useful for practicing physicians. The targeted readers include endocrinologists, endocrine surgeons, nuclear medicine specialists, pathologists, and oncologists. … This is an outstanding textbook … . surely a work to be added to the library of every clinician taking care of patients with thyroid cancer." (Brian W. Kim, Doody’s Review Service, May, 2006)
"This book includes almost twice as many chapters and contributors as the first edition. I especially enjoyed the addition of patient-focused content, including lists of useful books and Web sites and practical advice regarding radioiodine treatment … . an excellent, up-to-date book that is of practical value across all specialties involved in the management of thyroid cancer. It also provides a scholarly overview of the evidence base." (Jayne Franklyn, The New England Journal of Medicine, July, 2006)
"This is the second edition of an outstanding textbook edited by Leonard Wartofsky and Douglas Van Nostrand. The editors are to be congratulated on bringing together a remarkable array of multidisciplinary authors, who cover every topic pertaining to the clinical management of thyroid cancer. … Overall, I would highly recommend this book to all practitioners and associated specialties involved in the management of thyroid cancer. The book is clearly and concisely written, well illustrated … . an excellent textbook." (John Watkinson, Annals of the Royal College of Surgeons of England, Vol. 90, June, 2008)